Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 7021-7030 of 12127

Page
per page
  1. Picolinamide
    B6150 Picolinamide
    Summary: poly (ADP-ribose) synthetase inhibitor
      ≥83.33 mg/mL
  2. MRT68921
    B6174 MRT68921
    Summary: dual autophagy kinase ULK1/2 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥2.18 mg/mL
  3. CPI-637
    B7801 CPI-637
    Summary: CBP/EP300 bromodomain inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.3 mg/mL
  4. Phthalazinone pyrazole
    C3823 Phthalazinone pyrazole
    Summary: Aurora A kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥7.14 mg/mL
  5. 6-Aminonicotinamide
    C4497 6-Aminonicotinamide
    Summary: 6-phosphogluconate dehydrogenase inhibitor
      insoluble in H2O; insoluble in EtOH; ≥13.7 mg/mL
  6. bpV(HOpic) (potassium salt, technical grade)
    C4614 bpV(HOpic) (potassium salt, technical grade)
    Summary: protein tyrosine phosphatases (PTPs) inhibitor
      insoluble in EtOH; insoluble in DMSO; ≥90.4 mg/mL
  7. DRB
    C4798 DRB
    Summary: HIV transcription inhibitor
      insoluble in EtOH; insoluble in H2O; ≥12.6 mg/mL
  8. Ac-DEVD-AFC
    C5524 Ac-DEVD-AFC
    Summary: fluorogenic substrate for activated caspase-3
      insoluble in H2O; ≥73 mg/mL
  9. MJ33 (lithium salt)
    C5346 MJ33 (lithium salt)
    Summary: inhibitor of the acidic, calcium-independent (ai)PLA2 activity of Prdx6
      ≤2 mg/mL
  10. Amyloid Beta-Peptide (12-28) (human)
    A1123 Amyloid Beta-Peptide (12-28) (human)
    Summary: sequence H2N-VHHQKLVFFAEDVGSNK-OH
      ≥195.5 mg/mL

Items 7021-7030 of 12127

Page
per page